When MarketWatch first started delivering financial news and data exclusively online in 1997, about half of U.S. households that had internet access were connected through America Online. AOL was led Read more
Tag: Development
How Lehman and the iPhone reshaped financial markets
We are marking MarketWatch’s 25th anniversary by looking at the 25 biggest financial market events and developments we have covered. We previously highlighted the first five key events from the Read more
He saved credit cards, and now he’s inspiring crypto enthusiasts
As cryptocurrency enthusiasts look to build out the future of money, some are looking back for inspiration. Dee Hock, the Visa Inc. V, +2.20% founder who died this summer at Read more
Why aren’t new drugs that can help you lose weight more widely used?
A pair of new drugs offer something many Americans desperately want: a way to lose weight. In clinical trials, Novo Nordisk’s NOVO.B, +0.93% Wegovy helped adults lose about 15% of Read more
Hurricane Ian devastated your home – here’s the important first steps for disaster relief and insurance claims
The full financial and human price of Hurricane Ian’s destruction is still unknown, days after it lashed Florida and now with South Carolina fresh off its wrath. But even with Read more
Getting Medicare to cover Eisai and Biogen’s promising new Alzheimer’s therapy is ‘another bridge to cross’
An experimental Alzheimer’s disease treatment developed by Eisai and Biogen that appears to slow cognitive decline sent shares in both companies soaring, but some analysts are tempering their expectations until Read more
Eisai shares indicated sharply higher after trial of experimental drug slows Alzheimer’s progression
Eisai Co. shares were indicated sharply higher Wednesday morning after the Japanese drug maker and Biogen Inc. said their experimental Alzheimer’s disease drug significantly slowed progression of the disease in Read more
Alzheimer’s drug from Eisai, Biogen shows promise in large trial
Eisai Co. 4523, +0.89% and Biogen Inc. BIIB, +1.04% said their experimental Alzheimer’s disease drug significantly slowed progression of the memory-robbing disease in a large study, bolstering the drug’s prospects for approval. The pharmaceutical companies Read more
Ex-Nigerian official sentenced to 5 years for stealing from U.S. disaster relief funds and the strong dollar is making European travel very attractive right now — with one important caveat
Hi, MarketWatchers. Don’t miss these top stories. ‘The motivation was greed, unrestrained greed’: Ex-Nigerian official sentenced to 5 years for stealing from U.S. disaster relief funds Prosecutors say Abidemi Rufai Read more
Opinion: Russia’s invasion has been very profitable for the IMF, which is gouging Ukraine and other countries in crisis
It has now been six months since Russia, in an outrageous act of aggression, launched its brutal and unprovoked full-scale invasion of my country. In that period, while much of Read more